DEVELOPMENT SITE ONLY
Please use current guidelines available on the UHNM intranet for patient treatment
Please use current guidelines available on the UHNM intranet for patient treatment
RECOGNITION AND ASSESSMENT
- Use this guideline only in patients where the most likely diagnosis is unstable angina
- To check you are using the correct guideline, use Assessment of chest pain suspected to be cardiac in origin guideline
Unstable angina is:
- Onset of frequent attacks of angina for the first time, or
- Sudden worsening of previously stable angina without change in medical treatment, or
- Recurrent angina at rest
An attack of angina that lasts >20 min or keeps recurring despite repeated use of glyceryl trinitrate (GTN) is an indication for immediate admission to hospital
Symptoms and signs
- Central chest pain/tightness or discomfort (pain can also occur in arms, shoulders, throat, jaw, teeth, back or upper abdomen)
- Breathlessness
- Marked sweating
Investigations
- ECG on admission, during further episodes of chest pain, and 24 hr after admission
- ST segment depression occurring only during pain suggests myocardial ischaemia (consider acute posterior infarction if seen in leads V1-3 only and slow to resolve; check V4R and V7-9)
- ST segment elevation occurring only during pain suggests coronary artery spasm (Prinzmetal angina) or acute infarction
- ST segment elevation that does not resolve rapidly after giving GTN suggests acute infarction - see Management of STEMI in Acute myocardial infarction guideline
- subsequent occurrence of deep symmetrical T-wave inversion without Q waves suggests ischaemia or NSTEMI
- Troponin I
- FBC, INR, APTT, U&E
- Random cholesterol
- Random glucose and HbA1c
Cardiac biomarkers
- Raised markers signify myocardial infarction, not unstable angina
- A raised troponin I concentration can suggest myocardial necrosis but can also occur in a number of other conditions:
- auto-immune disease
- congestive cardiac failure
- critical illness
- dilated cardiomyopathy
- extreme physical effort
- hypertension
- hypothyroidism
- multiple injury
- myocarditis
- pericarditis
- pneumonia
- pulmonary embolism
- renal failure
- sepsis/septic shock
- subarachnoid haemorrhage
- tachyarrythmias
- vasculitis
Notes on clinical interpretation of troponin I results
- Two serial results <40 ng/L indicate a low risk of myocardial necrosis
- A rise or fall in troponin I of 20% reflects a potentially significant change. The greater the magnitude of change between 2 results, the greater the likelihood of acute myocardial infarction (AMI)
- Troponin I is a marker of myocardial necrosis and not a specific marker of AMI. Always interpret results in conjunction with clinical history and ECG findings
- A stable elevation in troponin I indicates chronic structural heart disease. All troponin I results ≥40 ng/L are important and predict an adverse outcome; it is therefore important to determine the cause
- Troponin is a tool to assist in diagnosis. Other findings and clinical judgement must be used when determining the cause of acute chest pain
Differential diagnosis
Chest pain with possible ECG changes
- Pulmonary embolism
- Aortic valve disease
- Hypertrophic cardiomyopathy
Chest pain where ECG changes unlikely
- Biliary colic
- Peptic ulcer
- Oesophageal pain
- Musculoskeletal pain
- Mitral valve prolapse
IMMEDIATE TREATMENT
- Aspirin 300 mg oral (chew and swallow)
- GTN spray to relieve symptoms: 400 microgram/metered dose spray 1-2 doses under tongue then close mouth. Bisoprolol 2.5 mg oral daily (or diltiazem 60 mg oral 8-hrly if beta-blocker contraindicated)
- Diamorphine 5 mg (2.5 mg in elderly or frail patients) by slow IV injection (1 mg/min)
- Metoclopramide 10 mg IV over 1-2 min (5 mg in young adults aged 15-19 yr <60 kg); allow ≥8 hr before repeating.
- Prescribe fondaparinux 2.5 mg once daily by SC injection
- Risk of bleeding is increased in patients with low body weight (<50 kg), physiological frailty, severe liver (bilirubin >2 x upper limit of normal and AST/ALT/alk phos >3 x upper limit of normal) or renal failure (eGFR <20 mL/min or serum creatinine ≥200 µmol/L), alcohol abuse, thrombocytopenia or defective platelet function or impaired clotting, anaemia and following surgery, trauma or haemorrhagic stroke
- seek advice from appropriate team (e.g. cardiology, renal, liver or haematology)
- If troponin I raised and myocardial necrosis suspected - see Management of NSTEMI in Acute myocardial infarction guideline
Referral to cardiology
- Admit all patients with unstable angina with dynamic ECG changes (ST or T wave inversion) under the care of the duty consultant cardiologist via CCU
- Consider patients with ST segment depression on ECG for urgent coronary angiography with a view to revascularisation. Contact on-call cardiology SpR/SHO
- Refer to on-call cardiology team for further management, patients who have:
- failed to respond to initial treatment
- ECG changes as above
- ongoing pain or ST segment depression/T-wave inversion
- positive cardiac biomarkers indicative of myocardial injury
- haemodynamic instability, arrhythmia
- early post-infarction unstable angina
- Discuss other patients with cardiology to consider dual antiplatelet therapy
SUBSEQUENT MANAGEMENT
- Aspirin 75 mg oral daily
- Continue beta-blocker (use diltiazem only if beta-blocker contraindicated)
- Atorvastatin 80 mg once daily for all acute coronary syndromes, unless history of CKD present when atorvastatin 20 mg once daily is used. Target is LDL cholesterol 1.8 mmol/L or non-HDL cholesterol 2.5 mmol/L
If responding:
- After 48 hr, if pain controlled, substitute isosorbide mononitrate SR 60 mg each morning for GTN spray (to minimise possibility of headache)
- Even if responding, inpatient assessment by cardiology team is indicated, if a candidate for an invasive approach
If not responding:
- GTN infusion - see Glyceryl trinitrate
- Diamorphine 5 mg (2.5 mg in elderly or frail patients) by slow IV injection (1 mg/min)
- Metoclopramide 10 mg IV over 1-2 min (5 mg in young adults aged 15-19 yr <60 kg); allow ≥8 hr before repeating
- If ECG changes or markers of myocardial injury suggest acute infarction - see Acute myocardial infarction guideline
- Consider patients who fail to settle or whose GTN infusion cannot be withdrawn for urgent coronary angiography with a view to revascularisation. Contact on-call cardiology SpR/SHO
MONITORING TREATMENT
- Hourly pulse and BP during GTN infusion until stable, then 4-hrly
- Repeat ECG after 24 hr
DISCHARGE AND FOLLOW-UP
- Discharge patients if pain has settled, if ECG had no dynamic changes and if markers of myocardial injury did not become abnormal
- Patients should be fully mobile and be able to climb stairs (assuming no other handicap precludes this)
- Patients with ongoing chest pain or dynamic ECG changes during their admission - refer to cardiology
- Positive troponin in the context of typical chest pain and dynamic ECG changes constitutes myocardial infarction in most cases - refer to cardiology
- Reconsider diagnosis and investigate further if appropriate
- If diagnosis of cardiac chest pain speculative, order an exercise test directly under admitting consultant rather than through a cardiologist
- If no alternative diagnosis more likely than unstable angina:
- continue aspirin, and beta-blocker or diltiazem (convert to equivalent once daily dose), statin and isosorbide mononitrate SR. Ensure GTN 400 microgram spray for sublingual use has been prescribed TTO and patient has been counselled on use
- give dietary advice to all patients
- review and address risk factors (smoking, hypertension, hyperlipidaemia, diabetes, obesity)
- if patient suitable for an invasive strategy and revascularisation, refer to cardiologist for further evaluation
- If patient able to perform exercise test and has no clinical signs suggestive of aortic stenosis or hypertrophic cardiomyopathy, request exercise ECG testing at the same time as an outpatient appointment